All I can say is that we have seen Berge moving away from convertible notes. That's verifiable. As far as the "non toxic" and "shareholder friendly" note, I would love to hear that explanation. The R/S may be a requirement for future funding. All we can do is wait it out. I hope Berge doesn't leave the post R/S at 6 billion. That would be ridiculous. You are right, we never seem to get the whole picture from Berge.
News 
Market Data 
Discover 
